We are monitoring the impact of COVID-19 on Latin America Solid Tumor Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6340
Share on
Share on

Latin America Solid Tumor Market Research Report – Segmented By Disease, Drugs and Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2021 to 2026)

Pulished: April, 2021
ID: 6340
Pages: 145

Latin America Solid Tumor Market Size (2021 to 2026)

The Solid Tumor Market in Latin America is predicted to grow at a prominent CAGR during the forecast period.

Factors such as the high increase in the aging population and deep-rooted healthcare infrastructure drive market growth. Around 18.1 million novel cancer cases were registered in 2018, and it is also estimated that 1 in 6 women and 1 in 5 men are likely to be affected with cancer. The rise in the investments made by the key market players and many public and private organizations making funds for R & D activities, which is predicted to favor the growth rate of the market.

High costs associated with the treatment procedures is restraining market growth. Furthermore, the complications related to the treatment, such as skin reactions (allergies, redness, anemia, and hair loss), may hinder the solid tumor market growth.

This research report on the Latin America Solid Tumor Market has been segmented and sub-segmented into the following categories:

By Disease:

  • Breast cancer     
  • Lung cancer      
  • Colorectal cancer
  • Prostate cancer
  • Cervical cancer
  • Others    

By Drugs:

  • Carboplatin       
  • Cisplatin  
  • Gemcitabine      
  • Paclitaxel
  • Doxorubicin      
  • Bevacizumab     
  • Erlotinib  
  • Sunitinib  
  • Everolimus      
  • Docetaxel       
  • Abiraterone     
  • Abiraterone acetate     
  • Cabazitaxel

By Country:

  • Brazil
  • Argentina
  • Chile
  • Mexico
  • Rest of Latin America

Regional Analysis:

The solid tumor market in Latin America is anticipated to have a steady CAGR growth during the assessment period. The market growth in this region is attributed to a rise in cancer cases and swelling occurrences of a few solid tumors cases. Moreover, the government's number of initiatives in accepting the growing demand for the solid tumor market impels market growth during the analysis period. Favorable reimbursement schemes are augmenting market growth. Brazil is set to dominate the region's solid tumor market because of the growing awareness about cancer and its treatment, improving healthcare infrastructure, and rising medical tourism. Growing outgoing towards healthcare and increasing discretionary expenses are likely to boost the region's growth during the historical period.

Key players leading the Latin American Solid Tumor Market profiled in this report are Baxter International, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, AstraZeneca plc, Abbott Laboratories, Inc., Amgen, Inc., Biogen Idec, Inc., Boehringer Ingelheim GmbH, Johnson & Johnson, GlaxoSmithKline plc, Kyowa Hakko Kirin Co., Ltd., and Sanofi among others.

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                   

               1.3 Base Currency, Base Year and Forecast Periods                           

               1.4 General Study Assumptions                  

2. Research Methodology                                          

               2.1 Introduction               

               2.2 Research Phases                      

                              2.2.1 Secondary Research            

                              2.2.2 Primary Research  

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation   

               2.3 Analysis Design                         

               2.4 Study Timeline                          

3. Overview                                     

               3.1 Executive Summary                 

               3.2 Key Inferences                          

               3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                        

               4.1 Market Drivers                         

               4.2 Market Restraints                    

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market                 

5. Market Segmentation                              

               5.1 Disease                       

                              5.1.1 Introduction           

                              5.1.2 Breast cancer         

                              5.1.3 Lung cancer            

                              5.1.4 Colorectal cancer  

                              5.1.5 Prostate cancer     

                              5.1.6 Cervical cancer      

                              5.1.7 Others       

                              5.1.8  Y-o-Y Growth Analysis, By disease 

                              5.1.9  Market Attractiveness Analysis, By disease 

                              5.1.10  Market Share Analysis, By disease

               5.2 Drugs                           

                              5.2.1 Introduction           

                              5.2.2 Carboplatin             

                              5.2.3 Cisplatin   

                              5.2.4 Gemcitabine           

                              5.2.5 Paclitaxel 

                              5.2.6 Doxorubicin            

                              5.2.7 Bevacizumab          

                              5.2.8 Erlotinib    

                              5.2.9 Sunitinib   

                              5.2.10 Everolimus            

                              5.2.11 Docetaxel             

                              5.2.12 Abiraterone          

                              5.2.13 Abiraterone acetate          

                              5.2.14 Cabazitaxel           

                              5.2.15 Y-o-Y Growth Analysis, By Drugs   

                              5.2.16 Market Attractiveness Analysis, By drugs   

                              5.2.17 Market Share Analysis, By drugs    

6. Geographical Analysis                              

               6.1 Introduction               

                              6.1.1 Regional Trends     

                              6.1.2 Impact Analysis      

                              6.1.3 Y-o-Y Growth Analysis         

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By disease

                                             6.1.3.3 By drugs

                              6.1.4  Market Attractiveness Analysis       

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By disease

                                             6.1.4.3 By drugs

                              6.1.5  Market Share Analysis        

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By disease

                                             6.1.5.3 By drugs

               6.2 Brazil                           

               6.3 Mexico                        

               6.4 Rest of Latin America                            

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis              

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services  

                              7.2.5 Competitive Rivalry within the Industry        

8. Market Leaders' Analysis                                        

               8.1 Abbott Laboratories                

                              8.1.1 Overview  

                              8.1.2 Product Analysis    

                              8.1.3 Financial analysis   

                              8.1.4 Recent Developments         

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View           

               8.2 Boehringer Ingelheim GmbH                

               8.3 Baxter International                

               8.4 Bristol-Myers Squibb Company                           

               8.5 F. Hoffmann-La Roche Ltd.                  

               8.6 Eli Lilly and Company                             

               8.7 Johnson & Johnson                 

               8.8 GlaxoSmithKline plc                 

               8.9 Kyowa Hakko Kirin Co., Ltd.                 

               8.10 Sanofi                        

9.Competitive Landscape                                           

               9.1 Market share analysis                            

               9.2 Merger and Acquisition Analysis                         

               9.3 Agreements, collaborations and Joint Ventures                           

               9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                            

Appendix                                          

               a) List of Tables                

               b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms Disease and Drug along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Solid Tumor Market, By Disease, From 2021 to 2026 (USD Million)
  2. Latin America Breast cancer Market, By Region, From 2021 to 2026 (USD Million)
  3. Latin America Lung cancer Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Liver cancer Market, By Region, From 2021 to 2026 (USD Million)
  5. Latin America Colorectal cancer Market, By Region, From 2021 to 2026 (USD Million)
  6. Latin America Cervical cancer Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Prostate cancer Market, By Region, From 2021 to 2026 (USD Million)
  8. Latin America Others Market, By Region, From 2021 to 2026 (USD Million)
  9. Latin America Solid Tumor Market, By Drugs, From 2021 to 2026 (USD Million)
  10. Latin America Carboplatin Market, By Region, From 2021 to 2026 (USD Million)
  11. Latin America Cisplatin Market, By Region, From 2021 to 2026 (USD Million)
  12. Latin America Doxorubicin Market, By Region, From 2021 to 2026 (USD Million)
  13. Latin America Paclitaxel Market, By Region, From 2021 to 2026 (USD Million)
  14. Latin America Erlotinib Market, By Region, From 2021 to 2026 (USD Million)
  15. Latin America Suntinib Market, By Region, From 2021 to 2026 (USD Million)
  16. Latin America Everolimus Market, By Region, From 2021 to 2026 (USD Million)
  17. Latin America Docetaxel Market, By Region, From 2021 to 2026 (USD Million)
  18. Latin America Abiraterone acetate Market, By Region, From 2021 to 2026 (USD Million)
  19. Latin America Others Market, By Region, From 2021 to 2026 (USD Million)
  20. Brazil Solid Tumor Market, By Disease, From 2021 to 2026 (USD Million)
  21. Brazil Solid Tumor Market, By Drugs, From 2021 to 2026 (USD Million)
  22. Argentina Solid Tumor Market, By Disease, From 2021 to 2026 (USD Million)
  23. Argentina Solid Tumor Market, By Drugs, From 2021 to 2026 (USD Million)
  24. Mexico Solid Tumor Market, By Disease, From 2021 to 2026 (USD Million)
  25. Mexico Solid Tumor Market, By Drugs, From 2021 to 2026 (USD Million)
  26. Rest of Latin America Solid Tumor Market, By Disease, From 2021 to 2026 (USD Million)
  27. Rest of Latin America Solid Tumor Market, By Drugs, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample